男人女人午夜视频免费,免费人妻无码不卡中文字幕系,国产A级三级三级三级,成年无码aⅴ片在线观看

轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)活性蛋白

Active Transforming Growth Factor Beta 3 (TGFb3)

TGF-B3; LAP; Latency-associated peptide

  • 轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)活性蛋白產(chǎn)品包裝(模擬)
  • 轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)活性蛋白產(chǎn)品包裝(模擬)
  • APB949Hu01.pngFigure. SDS-PAGE
  • 轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)活性蛋白Figure. Western Blot
  • Certificate通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

活性實(shí)驗(yàn)

Figure. The binding activity of TGFb3 with TGFbR2.
Transforming growth factor beta-3 (TGFb3) is a type of protein, known as a cytokine, which is involved in cell differentiation, embryogenesis and development. It belongs to a large family of cytokines called the Transforming growth factor beta superfamily. TGFb3 is believed to regulate molecules involved in cellular adhesion and extracellular matrix (ECM) formation during the process of palate development. It also plays an essential role in controlling the development of lungs in mammals, by also regulating cell adhesion and ECM formation in this tissue, and controls wound healing by regulating the movements of epidermal and dermal cells in injured skin. Besides, Transforming Growth Factor Beta Receptor II (TGFbR2) has been identified as an interactor of TGFb3, thus a binding ELISA assay was conducted to detect the interaction of recombinant human TGFb3 and recombinant human TGFbR2. Briefly, TGFb3 were diluted serially in PBS, with 0.01% BSA (pH 7.4). Duplicate samples of 100uL were then transferred to TGFbR2-coated microtiter wells and incubated for 2h at 37℃. Wells were washed with PBST and incubated for 1h with anti-TGFb3 pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody, wells were aspirated and washed 3 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50μL stop solution to the wells and read at 450nm immediately. The binding activity of TGFb3 and TGFbR2 was shown in Figure 1, and this effect was in a dose dependent manner.

用法

Reconstitute in 20mM Tris, 150mM NaCl (PH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

儲(chǔ)存

避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月,-80°C不超過(guò)12個(gè)月。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。

相關(guān)產(chǎn)品

編號(hào)適用物種:Homo sapiens (Human,人)應(yīng)用(僅供研究使用,不用于臨床診斷!)
RPB949Hu02轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
APB949Hu02轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)活性蛋白Cell?culture;?Activity?Assays.
RPB949Hu01轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
APB949Hu01轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)活性蛋白Cell?culture;?Activity?Assays.
PAB949Hu01轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)多克隆抗體IHC
PAB949Hu02轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)多克隆抗體IHC; ICC/IF
LAB949Hu71轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)多克隆抗體(生物素標(biāo)記)WB; IHC; ICC.
MAB949Hu23轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)單克隆抗體IHC; ICC/IF
RAB949Hu21轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)重組抗體WB; IF; ICC; IHC; IP; FCM.
MAB949Hu22轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)單克隆抗體WB
MAB949Hu24轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)單克隆抗體WB; IHC; ICC/IF
MAB949Hu26轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)單克隆抗體ICC/IF
MAB949Hu25轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)單克隆抗體ICC/IF
MAB949Hu21轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)單克隆抗體WB; IHC; ICC/IF
SEB949Hu轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)Enzyme-linked immunosorbent assay for Antigen Detection.
SCB949Hu轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法)Chemiluminescent immunoassay for Antigen Detection.
LMB949Hu轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)FLIA Kit for Antigen Detection.
PSB949Hu01轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)抗體對(duì)ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays.
KSB949Hu01轉(zhuǎn)化生長(zhǎng)因子β3(TGFb3)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法)Main materials for "Do It (ELISA Kit) Yourself".

參考文獻(xiàn)

雜志參考文獻(xiàn)
PLoS ONEA Combinatorial Relative Mass Value Evaluation of Endogenous Bioactive Proteins in Three-Dimensional Cultured Nucleus Pulposus Cells of Herniated Intervertebral Discs: Identification of Potential Target Proteins for Gene Therapeutic Approaches[Plosone: Source]
J Reprod ImmunolThe immunomodulating effect of seminal plasma on T cells[PubMed: 25799173]
Fertility and SterilityInfluence of vitamin D and transforming growth factor β3 serum concentrations, obesity, and family history on the risk for uterine fibroids[pubmed:27743697]
Eur J Pharm BiopharmNew scaffolds encapsulating TGF-β3/BMP-7 combinations driving strong chondrogenic differentiation[pubmed:28087378]
Transforme edici büyüme fakt?rü-beta-1 n?tralizan antikoru ve transforme edici büyüme fakt?rü-beta-3'ün trakeal darl?k geli?imi üzerine etkileri[10.5606/tgkdc.dergisi.2017.14302]
Fertility and SterilityUlipristal acetate decreases transforming growth factor β3 serum and tumor tissue concentrations in patients with uterine fibroids[Pubmed:29525690]
Scientific ReportsTGF-β concentrations and activity are down-regulated in the aqueous humor of patients with neovascular age-related macular degeneration[Pubmed:29795291]
Immunology?LettersThe involvement of multifunctional TGF-β and related cytokines in pathogenesis of endometriosis[Pubmed: 30367890]
Cell?ReportsTransforming Growth Factor-β3 Regulates Adipocyte Number in Subcutaneous White Adipose Tissue[Pubmed: 30332637]
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESTemporal TGF-β Supergene Family Signalling Cues Modulating Tissue Morphogenesis: Chondrogenesis within a Muscle Tissue Model?[Pubmed: 32660137]
Equine Vet JLimited added value of negative pressure wound therapy compared to calcium alginate dressings for second intention healing in a non?\contaminated and??-[34115409]
AAPS PharmSciTechNanoparticles and Nanostructured Films with TGF-β3: Preparation, Characterization, and Efficacy[34378118]